🇩🇪 Germany Country × Condition
relapse recurrence Clinical Trials in Germany
Active clinical trials for relapse recurrence with research sites in Germany. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 2 // Recruiting: 2 Phases: Phase 2, Phase 3 // Updated: Daily
Total Trials
2
Recruiting Now
2
Country
🇩🇪 Germany
Active Trials in Germany (2)
NCT04984837 Phase 2
Recruiting
Study of Lacutamab in Peripheral T-cell Lymphoma
Enrollment
56 pts
Country
🇩🇪 Germany
The Lymphoma Academic Research Orga...
View Trial → NCT06713837 Phase 3
Recruiting
IMPACT-AML: A Randomized Pragmatic Clinical Trial for Relapsed or Refractory Acute Myeloid Leukemia.
Enrollment
339 pts
Country
🇩🇪 Germany
Istituto Romagnolo per lo Studio de...
View Trial → Frequently Asked Questions
How many relapse recurrence clinical trials are active in Germany?
There are currently 2 active clinical trials for relapse recurrence with sites in Germany, of which 2 are actively recruiting patients.
How can I join a relapse recurrence clinical trial in Germany?
To join a relapse recurrence clinical trial in Germany, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Germany directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are relapse recurrence trials in Germany?
Active relapse recurrence trials in Germany span Phase 2, Phase 3. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.